Corrigendum to "Does Natalizumab treatment increase the risk of herpes simplex encephalitis in multiple sclerosis? Case and discussion" [Multiple Scler. Relat. Disord. 2 (4) (2013) 385-387].

Sharma, Kanchan; Ballham, Samantha A; Inglis, Kirsty E A; Renowden, Shelley; Cottrell, David A

Sharma, Kanchan; Ballham, Samantha A; Inglis, Kirsty E A; Renowden, Shelley; Cottrell, David A.

Afiliação

Sharma K; Department of Neurology, Frenchay Hospital, University of Bristol, North Bristol NHS Trust, Bristol BS16 1LE, UK.
Ballham SA; Department of Neurology, Frenchay Hospital, University of Bristol, North Bristol NHS Trust, Bristol BS16 1LE, UK.
Inglis KE; Department of Neurology, Frenchay Hospital, University of Bristol, North Bristol NHS Trust, Bristol BS16 1LE, UK.
Renowden S; Department of Neuroradiology, Frenchay Hospital, University of Bristol, North Bristol NHS Trust, Bristol BS16 1LE, UK.
Cottrell DA; Department of Neurology, Frenchay Hospital, University of Bristol, North Bristol NHS Trust, Bristol BS16 1LE, UK. Electronic address: david.cottrell@nbt.nhs.uk.

Mult Scler Relat Disord ; 3(1): 136-7, 2014 Jan.

Article em En | MEDLINE | ID: mdl-25877985

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google